Efficacy and safety of percutaneous coronary intervention in patients with coronary heart disease undergoing hemodialysis

被引:0
|
作者
Ni, Zhuhua [1 ]
Wang, Lefeng [1 ]
Yang, Xinchun [1 ]
Wang, Hongshi [1 ]
Xu, Li [1 ]
Li, Weiming [1 ]
Xia, Kun [1 ]
Liu, Yu [1 ]
He, Jifang [1 ]
Chi, Yonghui [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 10期
关键词
Coronary heart disease; End-stage renal disease; Hemodialysis; Percutaneous coronary intervention; STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; SIROLIMUS-ELUTING STENTS; BYPASS GRAFT-SURGERY; BARE-METAL STENTS; ARTERY-DISEASE; DIALYSIS PATIENTS; UNITED-STATES; REVASCULARIZATION; INITIATION;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Percutaneous coronary intervention for patients with Coronary Heart Disease (CHD) accompanying End-Stage Renal Disease (ESRD) on hemodialysis therapy is complicated due to the presence of complex lesions and the associated severity of complications and high mortality rates. This study aimed to investigate the efficacy and safety and to simultaneously delineate optimal procedural algorithms and therapeutic strategies of PCI as the preferred revascularization approach in a limited population. A total of 18 patients with CHD accompanying ESRD on dialysis therapy who underwent PCI were analysed retrospectively. The procedural flowchart before and after PCI was described. The instant procedural success rate and peri-and post-procedural complications were analysed. Out-hospital follow-up data were also recorded. Twenty-eight PCI procedures were successfully performed in the 18 patients. The average number of stents was 2.2 +/- 1.6 (1-6) per procedure, all of which were drug-eluting stents. Moderate to severe calcification in the coronary artery was found in 15 patients (83.3%), and rotational atherectomy was performed in four patients. The median follow-up duration was 18.9 (4-34) months. The degree of angina pectoris reduced in all patients, with no recurrence in 10 patients; the degree of angina pectoris reduced by one to two scales in eight patients after PCI. In-stent restenosis occurred in four patients (22.2%). One patient died after the fourth PCI procedure. PCI can be performed safely with high success rates in carefully selected patients with CHD accompanying ESRD on dialysis therapy and the symptoms would be alleviated effectively after optimizing procedural algorithms and therapeutic strategies.
引用
收藏
页码:4715 / 4721
页数:7
相关论文
共 50 条
  • [41] Safety and Efficacy of Adjunctive Cilostazol in Patients with Left Main Disease Undergoing Percutaneous Coronary Intervention with Drug Eluting Stent
    Poddar, Kanhaiya L.
    Rha, Seung-Woon
    Park, Ji Young
    Ramasamy, Sureshkumar
    Wang, Lin
    Choi, Byoung Geol
    Kim, Ji Bak
    Shin, Seung Yong
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 109B - 110B
  • [42] SAFETY AND OUTCOMES OF BIVALIRUDIN IN DIALYSIS PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Delhaye, Cedric
    Maluenda, Gabriel
    Wakabayashi, Kohei
    Ben-Dor, Itsik
    Collins, Sara D.
    Syed, Asmir I.
    Gonzalez, Manuel A.
    Gaglia, Michael A.
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [43] Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
    Zheng, Guo Hua
    Liu, Jian Ping
    Chu, Jian Feng
    Mei, Lijuan
    Chen, Hai Ying
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [44] The obesity paradox of mortality in patients with coronary artery disease undergoing percutaneous coronary intervention
    Lin, Gen-Min
    Li, Yi-Hwei
    Jaiteh, Lamin E. S.
    Han, Chih-Lu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 597 - 597
  • [45] Hyperuricemia and severity of coronary artery disease in patients undergoing selective percutaneous coronary intervention
    刘勇
    陈丽玲
    谭宁
    周颖玲
    何鹏程
    谢年谨
    罗建方
    陈津
    陈纪言
    South China Journal of Cardiology, 2010, 11 (04) : 195 - 202
  • [46] Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention
    Massalha, Samia
    Luria, Lior
    Kerner, Arthur
    Roguin, Ariel
    Abergel, Eitan
    Hammerman, Haim
    Boulos, Monther
    Dragu, Robert
    Kapeliovich, Michael R.
    Beyar, Rafael
    Nikolsky, Eugenia
    Aronson, Doron
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (06) : 455 - 462
  • [47] The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention - Insights from a large regional registry of contemporary percutaneous coronary intervention
    Gurm, Hitinder S.
    Smith, Dean E.
    Collins, J. Stewart
    Share, David
    Riba, Arthur
    Carter, Andrew J.
    LaLonde, Thomas
    Kline-Rogers, Eva
    O'Donnell, Michael
    Changezi, Hameem
    Zughaib, Marcel
    Safian, Robert
    Moscucci, Mauro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (05) : 529 - 535
  • [48] Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease
    Weintraub, William S.
    Boden, William E.
    JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1190 - 1194
  • [49] Efficacy and safety of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention with stent or concomitant acute coronary syndrome
    Chueh, Han-Hsin
    Huang, Shih-Tsung
    Hsiao, Fei-Yuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 125 - 126